Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CEP78 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA561823
Description
Immunogen sequence: ALETNTTLVV LDIRKNPLID HSMMKAVIKK VLQNGRSAKS EYQWITSPSV KEPSKTAKQK RRTIILGSGH KGKATIRIGL ATKKPVSSGR K Highest antigen sequence identity to the following orthologs: Mouse - 87%, Rat - 84%.
This gene encodes a centrosomal protein that is both required for the regulation of centrosome-related events during the cell cycle, and required for ciliogenesis. The encoded protein has an N-terminal leucine-rich repeat (LRR) domain with six consecutive LRR repeats, and a C-terminal coiled-coil domain. It interacts with the N-terminal catalytic domain of polo-like kinase 4 (PLK4) and colocalizes with PLK4 to the distal end of the centriole. Naturally occurring mutations in this gene cause defects in primary cilia that result in retinal degeneration and sensorineural hearing loss which are associated with cone-rod degeneration disease as well as Usher syndrome. Low expression of this gene is associated with poor prognosis of colorectal cancer patients.
Specifications
CEP78 | |
Polyclonal | |
Unconjugated | |
CEP78 | |
5730599I05Rik; C9orf81; centrosomal protein 78; centrosomal protein 78kDa; centrosomal protein of 78 kDa; Cep78; D030027P05; IP63 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
84131 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q5JTW2 | |
CEP78 | |
Recombinant protein corresponding to Human CEP78. Recombinant protein control fragment (Product #RP-92996). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction